Barrington Research Reiterates Outperform on Concentrix, Maintains $165 Price Target
Portfolio Pulse from richadhand@benzinga.com
Barrington Research analyst Vincent Colicchio has reiterated an Outperform rating on Concentrix (NASDAQ:CNXC) and maintained a $165 price target.
June 26, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research analyst Vincent Colicchio reiterated an Outperform rating on Concentrix (NASDAQ:CNXC) and maintained a $165 price target.
The reiteration of the Outperform rating and maintenance of the $165 price target by Barrington Research analyst Vincent Colicchio indicates a positive outlook for Concentrix's stock. This news is likely to have a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100